APG-2575 (Lisaftoclax)

Lisaftoclax · Ascentage Pharma Group Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for APG-2575 (Lisaftoclax), covering 2025-11-25 to 2025-11-25. Get the full timeline:

Most recent: Clinical Trial Update: A Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid Leukemia [Phase 3]

See pricing